Fluorine in PDB 5i4v: Discovery of Novel, Orally Efficacious Liver X Receptor (Lxr) Beta Agonists
Protein crystallography data
The structure of Discovery of Novel, Orally Efficacious Liver X Receptor (Lxr) Beta Agonists, PDB code: 5i4v
was solved by
G.Chen,
B.M.Mckeever,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
47.72 /
2.61
|
Space group
|
P 21 21 21
|
Cell size a, b, c (Å), α, β, γ (°)
|
68.637,
101.221,
143.274,
90.00,
90.00,
90.00
|
R / Rfree (%)
|
20.8 /
24.8
|
Fluorine Binding Sites:
The binding sites of Fluorine atom in the Discovery of Novel, Orally Efficacious Liver X Receptor (Lxr) Beta Agonists
(pdb code 5i4v). This binding sites where shown within
5.0 Angstroms radius around Fluorine atom.
In total 6 binding sites of Fluorine where determined in the
Discovery of Novel, Orally Efficacious Liver X Receptor (Lxr) Beta Agonists, PDB code: 5i4v:
Jump to Fluorine binding site number:
1;
2;
3;
4;
5;
6;
Fluorine binding site 1 out
of 6 in 5i4v
Go back to
Fluorine Binding Sites List in 5i4v
Fluorine binding site 1 out
of 6 in the Discovery of Novel, Orally Efficacious Liver X Receptor (Lxr) Beta Agonists
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 1 of Discovery of Novel, Orally Efficacious Liver X Receptor (Lxr) Beta Agonists within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F501
b:89.0
occ:1.00
|
F2
|
A:67S501
|
0.0
|
89.0
|
1.0
|
C7
|
A:67S501
|
1.3
|
81.1
|
1.0
|
F3
|
A:67S501
|
2.1
|
83.3
|
1.0
|
F1
|
A:67S501
|
2.2
|
93.5
|
1.0
|
C6
|
A:67S501
|
2.3
|
68.3
|
1.0
|
C9
|
A:67S501
|
2.8
|
69.9
|
1.0
|
C8
|
A:67S501
|
2.8
|
66.8
|
1.0
|
CD2
|
A:LEU345
|
3.2
|
39.2
|
1.0
|
N2
|
A:67S501
|
3.4
|
54.4
|
1.0
|
CE1
|
A:PHE268
|
3.7
|
34.3
|
1.0
|
CD1
|
A:LEU442
|
4.0
|
32.0
|
1.0
|
O1
|
A:67S501
|
4.1
|
77.7
|
1.0
|
C10
|
A:67S501
|
4.2
|
63.5
|
1.0
|
CD1
|
A:PHE268
|
4.4
|
34.3
|
1.0
|
CZ
|
A:PHE268
|
4.4
|
33.2
|
1.0
|
OG1
|
A:THR272
|
4.5
|
37.7
|
1.0
|
C5
|
A:67S501
|
4.5
|
51.6
|
1.0
|
CG
|
A:LEU345
|
4.6
|
37.1
|
1.0
|
N3
|
A:67S501
|
4.8
|
60.5
|
1.0
|
CD2
|
A:LEU442
|
4.8
|
30.9
|
1.0
|
|
Fluorine binding site 2 out
of 6 in 5i4v
Go back to
Fluorine Binding Sites List in 5i4v
Fluorine binding site 2 out
of 6 in the Discovery of Novel, Orally Efficacious Liver X Receptor (Lxr) Beta Agonists
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 2 of Discovery of Novel, Orally Efficacious Liver X Receptor (Lxr) Beta Agonists within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F501
b:93.5
occ:1.00
|
F1
|
A:67S501
|
0.0
|
93.5
|
1.0
|
C7
|
A:67S501
|
1.3
|
81.1
|
1.0
|
F2
|
A:67S501
|
2.2
|
89.0
|
1.0
|
F3
|
A:67S501
|
2.2
|
83.3
|
1.0
|
C6
|
A:67S501
|
2.3
|
68.3
|
1.0
|
N2
|
A:67S501
|
2.5
|
54.4
|
1.0
|
OG1
|
A:THR272
|
3.5
|
37.7
|
1.0
|
N
|
A:THR272
|
3.5
|
34.5
|
1.0
|
CB
|
A:PHE271
|
3.5
|
34.5
|
1.0
|
C8
|
A:67S501
|
3.6
|
66.8
|
1.0
|
C
|
A:PHE271
|
3.7
|
34.6
|
1.0
|
CA
|
A:THR272
|
3.8
|
33.6
|
1.0
|
C5
|
A:67S501
|
3.9
|
51.6
|
1.0
|
O
|
A:PHE271
|
4.0
|
34.5
|
1.0
|
CD2
|
A:LEU345
|
4.2
|
39.2
|
1.0
|
O
|
A:PHE268
|
4.3
|
34.9
|
1.0
|
CA
|
A:PHE271
|
4.3
|
34.4
|
1.0
|
C9
|
A:67S501
|
4.3
|
69.9
|
1.0
|
CB
|
A:THR272
|
4.3
|
35.9
|
1.0
|
CE1
|
A:PHE268
|
4.4
|
34.3
|
1.0
|
CD1
|
A:PHE268
|
4.6
|
34.3
|
1.0
|
CG
|
A:PHE271
|
4.6
|
34.8
|
1.0
|
C10
|
A:67S501
|
4.6
|
63.5
|
1.0
|
CD2
|
A:PHE271
|
4.7
|
36.1
|
1.0
|
N3
|
A:67S501
|
4.7
|
60.5
|
1.0
|
N1
|
A:67S501
|
4.7
|
44.0
|
1.0
|
C11
|
A:67S501
|
4.8
|
43.5
|
1.0
|
|
Fluorine binding site 3 out
of 6 in 5i4v
Go back to
Fluorine Binding Sites List in 5i4v
Fluorine binding site 3 out
of 6 in the Discovery of Novel, Orally Efficacious Liver X Receptor (Lxr) Beta Agonists
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 3 of Discovery of Novel, Orally Efficacious Liver X Receptor (Lxr) Beta Agonists within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F501
b:83.3
occ:1.00
|
F3
|
A:67S501
|
0.0
|
83.3
|
1.0
|
C7
|
A:67S501
|
1.3
|
81.1
|
1.0
|
F2
|
A:67S501
|
2.1
|
89.0
|
1.0
|
F1
|
A:67S501
|
2.2
|
93.5
|
1.0
|
C6
|
A:67S501
|
2.3
|
68.3
|
1.0
|
C8
|
A:67S501
|
3.0
|
66.8
|
1.0
|
C9
|
A:67S501
|
3.1
|
69.9
|
1.0
|
N2
|
A:67S501
|
3.2
|
54.4
|
1.0
|
OG1
|
A:THR272
|
3.3
|
37.7
|
1.0
|
CA
|
A:THR272
|
4.0
|
33.6
|
1.0
|
CB
|
A:THR272
|
4.2
|
35.9
|
1.0
|
C10
|
A:67S501
|
4.2
|
63.5
|
1.0
|
CD1
|
A:LEU453
|
4.2
|
30.0
|
1.0
|
C5
|
A:67S501
|
4.4
|
51.6
|
1.0
|
CE1
|
A:PHE268
|
4.4
|
34.3
|
1.0
|
O1
|
A:67S501
|
4.5
|
77.7
|
1.0
|
N
|
A:THR272
|
4.5
|
34.5
|
1.0
|
CG2
|
A:THR272
|
4.5
|
38.3
|
1.0
|
CZ
|
A:PHE268
|
4.6
|
33.2
|
1.0
|
CD2
|
A:LEU449
|
4.6
|
47.9
|
1.0
|
N3
|
A:67S501
|
4.7
|
60.5
|
1.0
|
CG
|
A:LEU449
|
4.8
|
48.8
|
1.0
|
CB
|
A:ALA275
|
4.8
|
30.3
|
1.0
|
CD1
|
A:LEU442
|
5.0
|
32.0
|
1.0
|
|
Fluorine binding site 4 out
of 6 in 5i4v
Go back to
Fluorine Binding Sites List in 5i4v
Fluorine binding site 4 out
of 6 in the Discovery of Novel, Orally Efficacious Liver X Receptor (Lxr) Beta Agonists
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 4 of Discovery of Novel, Orally Efficacious Liver X Receptor (Lxr) Beta Agonists within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
E:F501
b:0.5
occ:1.00
|
F2
|
E:67S501
|
0.0
|
0.5
|
1.0
|
C7
|
E:67S501
|
1.3
|
0.1
|
1.0
|
F3
|
E:67S501
|
2.2
|
0.0
|
1.0
|
F1
|
E:67S501
|
2.2
|
0.1
|
1.0
|
C6
|
E:67S501
|
2.3
|
89.1
|
1.0
|
C8
|
E:67S501
|
2.9
|
80.6
|
1.0
|
C9
|
E:67S501
|
2.9
|
81.3
|
1.0
|
CD2
|
E:LEU345
|
3.1
|
38.5
|
1.0
|
N2
|
E:67S501
|
3.4
|
75.3
|
1.0
|
CE1
|
E:PHE268
|
3.6
|
43.8
|
1.0
|
C10
|
E:67S501
|
4.2
|
77.2
|
1.0
|
O1
|
E:67S501
|
4.2
|
84.0
|
1.0
|
CD1
|
E:PHE268
|
4.2
|
42.0
|
1.0
|
CD1
|
E:LEU442
|
4.3
|
45.5
|
1.0
|
CZ
|
E:PHE268
|
4.4
|
44.0
|
1.0
|
OG1
|
E:THR272
|
4.4
|
40.6
|
1.0
|
CG
|
E:LEU345
|
4.5
|
37.7
|
1.0
|
C5
|
E:67S501
|
4.5
|
68.6
|
1.0
|
N3
|
E:67S501
|
4.8
|
74.4
|
1.0
|
CD2
|
E:LEU449
|
4.9
|
68.5
|
1.0
|
CD1
|
E:LEU345
|
5.0
|
37.3
|
1.0
|
CD2
|
E:LEU442
|
5.0
|
46.5
|
1.0
|
|
Fluorine binding site 5 out
of 6 in 5i4v
Go back to
Fluorine Binding Sites List in 5i4v
Fluorine binding site 5 out
of 6 in the Discovery of Novel, Orally Efficacious Liver X Receptor (Lxr) Beta Agonists
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 5 of Discovery of Novel, Orally Efficacious Liver X Receptor (Lxr) Beta Agonists within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
E:F501
b:0.1
occ:1.00
|
F1
|
E:67S501
|
0.0
|
0.1
|
1.0
|
C7
|
E:67S501
|
1.3
|
0.1
|
1.0
|
F3
|
E:67S501
|
2.2
|
0.0
|
1.0
|
F2
|
E:67S501
|
2.2
|
0.5
|
1.0
|
C6
|
E:67S501
|
2.3
|
89.1
|
1.0
|
N2
|
E:67S501
|
2.6
|
75.3
|
1.0
|
OG1
|
E:THR272
|
3.3
|
40.6
|
1.0
|
N
|
E:THR272
|
3.3
|
38.1
|
1.0
|
CB
|
E:PHE271
|
3.5
|
38.4
|
1.0
|
CA
|
E:THR272
|
3.6
|
39.3
|
1.0
|
C
|
E:PHE271
|
3.6
|
39.6
|
1.0
|
C8
|
E:67S501
|
3.6
|
80.6
|
1.0
|
C5
|
E:67S501
|
3.9
|
68.6
|
1.0
|
O
|
E:PHE271
|
4.0
|
39.1
|
1.0
|
CB
|
E:THR272
|
4.0
|
40.7
|
1.0
|
O
|
E:PHE268
|
4.1
|
39.9
|
1.0
|
CA
|
E:PHE271
|
4.2
|
38.8
|
1.0
|
C9
|
E:67S501
|
4.3
|
81.3
|
1.0
|
CE1
|
E:PHE268
|
4.5
|
43.8
|
1.0
|
CD2
|
E:LEU345
|
4.5
|
38.5
|
1.0
|
CD1
|
E:PHE268
|
4.6
|
42.0
|
1.0
|
CG
|
E:PHE271
|
4.6
|
37.9
|
1.0
|
C10
|
E:67S501
|
4.7
|
77.2
|
1.0
|
N3
|
E:67S501
|
4.8
|
74.4
|
1.0
|
CD2
|
E:PHE271
|
4.8
|
37.4
|
1.0
|
C11
|
E:67S501
|
4.8
|
51.0
|
1.0
|
N1
|
E:67S501
|
4.8
|
55.9
|
1.0
|
C
|
E:THR272
|
4.9
|
39.8
|
1.0
|
|
Fluorine binding site 6 out
of 6 in 5i4v
Go back to
Fluorine Binding Sites List in 5i4v
Fluorine binding site 6 out
of 6 in the Discovery of Novel, Orally Efficacious Liver X Receptor (Lxr) Beta Agonists
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 6 of Discovery of Novel, Orally Efficacious Liver X Receptor (Lxr) Beta Agonists within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
E:F501
b:0.0
occ:1.00
|
F3
|
E:67S501
|
0.0
|
0.0
|
1.0
|
C7
|
E:67S501
|
1.3
|
0.1
|
1.0
|
F2
|
E:67S501
|
2.2
|
0.5
|
1.0
|
F1
|
E:67S501
|
2.2
|
0.1
|
1.0
|
C6
|
E:67S501
|
2.3
|
89.1
|
1.0
|
C8
|
E:67S501
|
2.9
|
80.6
|
1.0
|
C9
|
E:67S501
|
3.0
|
81.3
|
1.0
|
N2
|
E:67S501
|
3.3
|
75.3
|
1.0
|
OG1
|
E:THR272
|
3.4
|
40.6
|
1.0
|
CD2
|
E:LEU449
|
3.7
|
68.5
|
1.0
|
C10
|
E:67S501
|
4.2
|
77.2
|
1.0
|
CA
|
E:THR272
|
4.2
|
39.3
|
1.0
|
CD2
|
E:LEU453
|
4.2
|
48.0
|
1.0
|
CB
|
E:THR272
|
4.2
|
40.7
|
1.0
|
O1
|
E:67S501
|
4.3
|
84.0
|
1.0
|
CE1
|
E:PHE268
|
4.4
|
43.8
|
1.0
|
C5
|
E:67S501
|
4.5
|
68.6
|
1.0
|
CZ
|
E:PHE268
|
4.6
|
44.0
|
1.0
|
CG2
|
E:THR272
|
4.6
|
42.2
|
1.0
|
N
|
E:THR272
|
4.6
|
38.1
|
1.0
|
N3
|
E:67S501
|
4.8
|
74.4
|
1.0
|
|
Reference:
Y.Zheng,
L.Zhuang,
K.Y.Fan,
C.M.Tice,
W.Zhao,
C.Dong,
S.D.Lotesta,
K.Leftheris,
P.R.Lindblom,
Z.Liu,
J.Shimada,
P.B.Noto,
S.Meng,
A.Hardy,
L.Howard,
P.Krosky,
J.Guo,
K.Lipinski,
G.Kandpal,
Y.Bukhtiyarov,
Y.Zhao,
D.Lala,
R.Van Orden,
J.Zhou,
G.Chen,
Z.Wu,
B.M.Mckeever,
G.M.Mcgeehan,
R.E.Gregg,
D.A.Claremon,
S.B.Singh.
Discovery of A Novel, Orally Efficacious Liver X Receptor (Lxr) Beta Agonist. J.Med.Chem. V. 59 3264 2016.
ISSN: ISSN 0022-2623
PubMed: 26990539
DOI: 10.1021/ACS.JMEDCHEM.5B02029
Page generated: Thu Aug 1 10:05:59 2024
|